MEDICLINIC INTERNATIONAL PLC

Board/Management Information • Mar 20, 2017

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9607Z

Mediclinic International PLC

20 March 2017

Mediclinic International plc

(Incorporated in England and Wales)

Company Number 8338604

LSE Share Code: MDC

JSE Share Code: MEI

NSX Share Code: MEP

ISIN: GB00B8HX8Z88

LEI: 2138002S5BSBIZTD5I60

("Mediclinic" or "the Company")

20 March 2017

BOARD COMMITTEE CHANGES

The Company announces that, following a review of the composition of the Board Committees, the membership of the Committees will be as follows, with effect from 17 March 2017.

·      The Audit and Risk Committee will continue to be chaired by Desmond Smith and its other members will comprise Alan Grieve, Seamus Keating and Trevor Petersen.

·      The Remuneration Committee will continue to be chaired by Trevor Petersen and its other members will comprise Prof Dr Robert Leu and Seamus Keating.

·      The Nomination Committee will be chaired by Dr Edwin Hertzog and its other members will comprise Jannie Durand (with Pieter Uys as his alternate), Prof Dr Robert Leu, Trevor Petersen and Desmond Smith.

·      The Clinical Performance and Sustainability Committee will continue to be chaired by Dr Edwin Hertzog and its members will comprise Nandi Mandela, Danie Meintjes and Prof Dr Robert Leu.

·      The Investment Committee will continue to be chaired by Dr Edwin Hertzog and its other members will comprise Jannie Durand (with Pieter Uys as his alternate), Alan Grieve, Seamus Keating, Danie Meintjes and Jurgens Myburgh.

Mediclinic's primary listing is on the Main Market of the LSE, with secondary listings on the JSE in South Africa and on the NSX in Namibia.

Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom

Website: www.mediclinic.com

Corporate broker: Morgan Stanley & Co International plc 

JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)

NSX sponsor: Simonis Storm Securities (Pty) Ltd

For further information please contact:

Mediclinic International plc

James Arnold, Head of Investor Relations

ir@mediclinic.com

Capita Company Secretarial Services Limited

Victoria Dalby

+44 (0)207 954 9600

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCSEDFESFWSESD